Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity. uri icon

Overview

abstract

  • [This corrects the article .].

authors

  • La Manna, Federico
  • De Menna, Marta
  • Patel, Nikhil
  • Karkampouna, Sofia
  • De Filippo, Maria Rosaria
  • Klima, Irena
  • Kloen, Peter
  • Beimers, Lijkele
  • Thalmann, George N
  • Pelger, Rob C M
  • Jacinto, Estela
  • Kruithof-de Julio, Marianna

publication date

  • February 3, 2021

Identity

PubMed Central ID

  • PMC7887433

Scopus Document Identifier

  • 85101197569

Digital Object Identifier (DOI)

  • 10.3389/fonc.2021.650623

PubMed ID

  • 33614519

Additional Document Info

volume

  • 11